Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel plus bivalirudin versus clopidogrel plus heparin in acute STEMI
2009-014343-36Phase 4Active
- Sponsor
- Deutsches Herzzentrum der Charité
- Start
- Aug 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in myocardial infarction (MI) comparing Prasugrel + bivalirudin with Clopidogrel + heparin (2 arms). Primary endpoint: Primary composite endpoint at 30 days. Started Aug 2009; status: active.
02
Drugs
prasugrelbivalirudinclopidogrelheparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-014343-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014343-36.